Tag: serious breach

Building Job Aids to Help Sites Classify Deviations Consistently

Posted on By digi

Building Job Aids to Help Sites Classify Deviations Consistently Building Job Aids to Help Sites Classify Deviations Consistently Introduction to Protocol Deviations and Violations In the context of clinical trials, accurately classifying protocol deviations and violations is crucial for ensuring compliance with regulatory standards and safeguarding patient safety. Deviations refer to departures from the protocol…

Read More “Building Job Aids to Help Sites Classify Deviations Consistently” »

Definitions: Deviation vs. Violation

Deviation, Major Deviation and Serious Breach: Where to Draw the Line

Posted on By digi

Deviation, Major Deviation and Serious Breach: Where to Draw the Line Deviation, Major Deviation and Serious Breach: Where to Draw the Line Clinical trials are pivotal for advancing medical knowledge and treatment options. However, the successful conduct of these trials necessitates strict adherence to protocols and regulatory requirements. Understanding the terminology related to non-compliance, specifically…

Read More “Deviation, Major Deviation and Serious Breach: Where to Draw the Line” »

Definitions: Deviation vs. Violation

Aligning Protocol, SOPs and IRB Documents on Deviation Terminology

Posted on By digi

Aligning Protocol, SOPs and IRB Documents on Deviation Terminology Clinical trials are integral to advancing medical knowledge and improving patient care. However, adherence to established protocols, Standard Operating Procedures (SOPs), and Institutional Review Board (IRB) documents is essential to maintain the integrity of these trials. This article serves as a comprehensive guide for clinical operations,…

Read More “Aligning Protocol, SOPs and IRB Documents on Deviation Terminology” »

Definitions: Deviation vs. Violation

Protocol Deviation vs Violation: GCP-Compliant Definitions for Global Trials

Posted on By digi

Protocol Deviation vs Violation: GCP-Compliant Definitions for Global Trials Protocol Deviation vs Violation: GCP-Compliant Definitions for Global Trials Understanding the distinction between protocol deviations and violations is crucial for the successful management of clinical trials. Compliance with Good Clinical Practice (GCP) is paramount across regions, including the US, UK, and EU. This tutorial provides a…

Read More “Protocol Deviation vs Violation: GCP-Compliant Definitions for Global Trials” »

Definitions: Deviation vs. Violation

How to Define Protocol Deviations and Violations for FDA, EMA and MHRA

Posted on By digi

How to Define Protocol Deviations and Violations for FDA, EMA and MHRA How to Define Protocol Deviations and Violations for FDA, EMA and MHRA Understanding the distinctions between protocol deviations and violations is critical for professionals involved in gcp trial management. Regulatory authorities such as the FDA, EMA, and MHRA have clear definitions and guidelines…

Read More “How to Define Protocol Deviations and Violations for FDA, EMA and MHRA” »

Definitions: Deviation vs. Violation

Preparing for Inspector Questions on Historical Non-Compliance Cases

Posted on By digi

Preparing for Inspector Questions on Historical Non-Compliance Cases Preparing for Inspector Questions on Historical Non-Compliance Cases The integrity and compliance of clinical trials are paramount in ensuring patient safety and the validity of data collected. With the increasing scrutiny from regulatory authorities such as the FDA, EMA, and MHRA, it is essential for clinical research…

Read More “Preparing for Inspector Questions on Historical Non-Compliance Cases” »

Dealing with Non-Compliance under GCP

Tracking Trends in GCP Non-Compliance Across Programs and Portfolios

Posted on By digi

Tracking Trends in GCP Non-Compliance Across Programs and Portfolios Tracking Trends in GCP Non-Compliance Across Programs and Portfolios Good Clinical Practice (GCP) is essential for ensuring the integrity of clinical trials and the safety of participants. However, non-compliance with GCP guidelines is a persistent challenge across clinical research landscapes worldwide. This comprehensive tutorial aims to…

Read More “Tracking Trends in GCP Non-Compliance Across Programs and Portfolios” »

Dealing with Non-Compliance under GCP

Using Non-Compliance Insights to Strengthen SOPs and Training

Posted on By digi

Using Non-Compliance Insights to Strengthen SOPs and Training In the landscape of clinical trials, compliance with Good Clinical Practice (GCP) is of paramount importance. Non-compliance can jeopardize the integrity of the data collected, the safety of participants, and the study’s overall success. As such, understanding non-compliance, identifying its causes, and implementing measures to prevent it…

Read More “Using Non-Compliance Insights to Strengthen SOPs and Training” »

Dealing with Non-Compliance under GCP

Case Studies: GCP Non-Compliance That Led to Warning Letters

Posted on By digi

Case Studies: GCP Non-Compliance That Led to Warning Letters Case Studies: GCP Non-Compliance That Led to Warning Letters In the highly regulated field of clinical research, adherence to Good Clinical Practice (GCP) is crucial to ensure the integrity of data and the safety of participants. This tutorial outlines notable case studies of non-compliance with GCP…

Read More “Case Studies: GCP Non-Compliance That Led to Warning Letters” »

Dealing with Non-Compliance under GCP

Managing Non-Compliance in Vendor, CRO and Partner Activities

Posted on By digi

Managing Non-Compliance in Vendor, CRO and Partner Activities Managing Non-Compliance in Vendor, CRO and Partner Activities Clinical trials are essential in bringing new therapies to market, and adherence to Good Clinical Practice (GCP) is crucial for the integrity of the research. Non-compliance can arise from various sources, including vendors, Contract Research Organizations (CROs), and other…

Read More “Managing Non-Compliance in Vendor, CRO and Partner Activities” »

Dealing with Non-Compliance under GCP